David Szekeres

David L.
Szekeres is Executive Chairman at Annai Systems, Inc. since 2014.
He is Chairman at GRI Bio, Inc. starting in 2023.
He serves as Director at the Association of Corporate Counsel since 2010, Anoichi Biopharma, Inc. since 2011, Animantis LLC, CureMatch, Inc., and Colossal Biosciences, Inc. He is Trustee at Sanford Burnham Prebys Medical Discovery Institute.
He became President of Connect Biopharma Holdings Ltd. in 2024.
Former roles include Chairman at Vallon Pharmaceuticals, Inc., Director at Edico Genome Corp.
from 2014 to 2018, Attorney at O'Melveny & Myers LLP from 2001 to 2003, Attorney at Latham & Watkins LLP from 2006 to 2008, Senior Associate at Robertson Stephens, Inc. in 2000, CFO, Secretary, CAO & General Counsel at Regulus Therapeutics, Inc. in 2015, Head-Mergers & Acquisitions, Governance at Life Technologies Corp.
from 2008 to 2014, and Chief Legal, Business & Administrative Officer at Heron Therapeutics, Inc. from 2016 to 2023.
Education includes graduate degree from Duke University in 2000 and undergraduate degree from the University of California, Irvine in 1997.